BioSpace News Archive

Drug Development

Novartis AG Announces Robust Phase 3 Results For QVA149 And NVA237 And Submits Regulatory Applications To U.S. FDA

January 8, 2015
·
12 min read
Deals

Bay Area’s Pulmonx, Inc. Snaps Up Aeris Therapeutics, Inc. for Undisclosed Amount

January 8, 2015
·
2 min read
Business

Insulet Corporation Cuts Revenue Outlook; Shuffles Executive Deck

January 8, 2015
·
1 min read
Genetown

Boston Children’s Hospital Release: Tracking Subtle Brain Mutations, Systematically

January 8, 2015
·
4 min read
Business

Xeris Pharmaceuticals Completes $17.9M Series B Round And Appoints Phillip Johnson As Chief Financial Officer

January 8, 2015
·
5 min read
Business

Nephros Inc. Appoints Paul A. Mieyal as Acting Chief Executive Officer and Daron Evans as Chairman of the Board of Directors

January 8, 2015
·
6 min read
Biotech Bay

Avalanche Biotechnologies Prices Public Offering Of $141.6 Million Of Common Stock

January 8, 2015
·
2 min read
Drug Development

Biogen Idec Reports Positive Top-Line Results From Phase 2 Anti-LINGO-1 Trial In People With Acute Optic Neuritis

January 8, 2015
·
5 min read
Drug Development

Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.)'s Lead Candidate Delafloxacin Yields Positive Top-Line Results In Phase 3 Study In Patients With ABSSSI

January 8, 2015
·
3 min read
Drug Development

Protalix Biotherapeutics, Inc. Reports Positive Interim Data From Phase 1/2 Clinical Trial Of PRX-102 For The Treatment Of Fabry Disease

January 8, 2015
·
8 min read